Back to GetFilings.com



Table of Contents

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

Form 10-Q

 


 

(Mark One)

x   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2004

 

OR

 

¨   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from              to             

 

Commission file number: 001-15971

 


 

Memry Corporation

(Exact name of registrant as specified in its charter)

 


 

Delaware   06-1084424

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

3 Berkshire Blvd., Bethel, Connecticut   06801
(Address of principal executive offices)   (Zip Code)

 

(203) 739-1100

(Registrant’s telephone number, including area code)

 

N/A

(Former name, former address and former fiscal year, if changed since last report)

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes  ¨    No   x

 

As of April 28, 2004, 25,570,419 shares of the registrant’s common stock, par value $.01 per share, were issued and outstanding.

 



Table of Contents

MEMRY CORPORATION

FORM 10-Q

For the quarter ended March 31, 2004

 

INDEX

 

PART I — FINANCIAL INFORMATION

    
   

ITEM 1.

   Financial Statements:    2
         Consolidated Balance Sheets as of March 31, 2004 (Unaudited) and June 30, 2003    2
         Consolidated Statements of Income (Unaudited) for the three and nine months ended March 31, 2004 and 2003    3
         Consolidated Statements of Cash Flows (Unaudited) for the nine months ended March 31, 2004 and 2003    5
         Notes to Consolidated Financial Statements (Unaudited)    6
   

ITEM 2.

   Management’s Discussion and Analysis of Financial Condition and Results of Operations    8
   

ITEM 3.

   Quantitative and Qualitative Disclosures About Market Risk    12
   

ITEM 4.

   Controls and Procedures    12

PART II — OTHER INFORMATION

    
   

ITEM 2.

   Change in Securities, Use of Proceeds and Issuer Purchases of Equity Securities    14
   

ITEM 6.

   Exhibits and Reports on Form 8-K    14

SIGNATURES

   16

 

1


Table of Contents

PART I — FINANCIAL INFORMATION

 

ITEM 1. Financial Statements

 

Memry Corporation & Subsidiaries

Consolidated Balance Sheets

 

    

March 31,

2004


   

June 30,

2003


 
     (Unaudited)        

ASSETS

                

Current Assets

                

Cash and cash equivalents

   $ 9,997,000     $ 7,509,000  

Accounts receivable, less allowance for doubtful accounts

     4,205,000       3,809,000  

Inventories, net

     2,845,000       3,353,000  

Prepaid expenses and other current assets

     241,000       74,000  

Note receivable

     110,000       —    

Income tax refund receivable

     70,000       109,000  
    


 


Total current assets

     17,468,000       14,854,000  
    


 


Property, Plant, and Equipment

     14,480,000       13,913,000  

Less accumulated depreciation

     (9,148,000 )     (7,873,000 )
    


 


       5,332,000       6,040,000  
    


 


Other Assets

                

Patents and patent rights, less accumulated amortization

     967,000       1,067,000  

Goodwill

     1,038,000       1,038,000  

Note receivable

     —         110,000  

Deferred tax asset

     6,199,000       6,806,000  

Other assets

     227,000       212,000  
    


 


       8,431,000       9,233,000  
    


 


     $ 31,231,000     $ 30,127,000  
    


 


LIABILITIES AND STOCKHOLDERS’ EQUITY

                

Current Liabilities

                

Accounts payable

   $ 717,000     $ 611,000  

Accrued expenses

     2,041,000       1,976,000  

Notes payable

     320,000       912,000  
    


 


Total current liabilities

     3,078,000       3,499,000  
    


 


Notes Payable, less current maturities

     1,239,000       980,000  
    


 


Stockholders’ Equity

                

Common stock

     256,000       255,000  

Additional paid-in capital

     49,082,000       48,906,000  

Accumulated deficit

     (22,424,000 )     (23,513,000 )
    


 


Total stockholders’ equity

     26,914,000       25,648,000  
    


 


     $ 31,231,000     $ 30,127,000  
    


 


 

See Notes to Consolidated Financial Statements.

 

2


Table of Contents

Memry Corporation & Subsidiaries

Consolidated Statements of Income

For the Three Months Ended March 31, 2004 and 2003

(Unaudited)

 

     2004

    2003

 

Revenues:

                

Product sales

   $ 8,265,000     $ 8,251,000  

Research and development

     306,000       209,000  
    


 


       8,571,000       8,460,000  
    


 


Cost of Revenues:

                

Manufacturing

     4,947,000       5,567,000  

Research and development

     213,000       167,000  
    


 


       5,160,000       5,734,000  
    


 


Gross profit

     3,411,000       2,726,000  
    


 


Operating Expenses:

                

Research and development

     758,000       631,000  

General, selling and administrative

     2,057,000       1,638,000  
    


 


       2,815,000       2,269,000  
    


 


Operating income

     596,000       457,000  
    


 


Interest:

                

Interest expense

     (18,000 )     (30,000 )

Interest income

     21,000       16,000  
    


 


       3,000       (14,000 )
    


 


Income before income taxes

     599,000       443,000  

Provision for income taxes

     234,000       166,000  
    


 


Net income

   $ 365,000     $ 277,000  
    


 


Basic Earnings Per Share

   $ 0.01     $ 0.01  

Diluted Earnings Per Share

   $ 0.01     $ 0.01  

 

See Notes to Consolidated Financial Statements.

 

3


Table of Contents

Memry Corporation & Subsidiaries

Consolidated Statements of Income

For the Nine Months Ended March 31, 2004 and 2003

(Unaudited)

 

     2004

    2003

 

Revenues:

                

Product sales

   $ 24,119,000     $ 26,158,000  

Research and development

     715,000       594,000  
    


 


       24,834,000       26,752,000  
    


 


Cost of Revenues:

                

Manufacturing

     14,642,000       17,241,000  

Research and development

     390,000       371,000  
    


 


       15,032,000       17,612,000  
    


 


Gross profit

     9,802,000       9,140,000  
    


 


Operating Expenses (Income):

                

Research and development

     2,246,000       1,847,000  

General, selling and administrative

     5,753,000       5,201,000  

Gain on disposal of assets

     —         (12,000 )
    


 


       7,999,000       7,036,000  
    


 


Operating income

     1,803,000       2,104,000  
    


 


Interest:

                

Interest expense

     (80,000 )     (98,000 )

Interest income

     62,000       44,000  
    


 


       (18,000 )     (54,000 )
    


 


Income before income taxes

     1,785,000       2,050,000  

Provision (benefit) for income taxes

     696,000       (6,742,000 )
    


 


Net income

   $ 1,089,000     $ 8,792,000  
    


 


Basic Earnings Per Share

   $ 0.04     $ 0.35  

Diluted Earnings Per Share

   $ 0.04     $ 0.34  

 

See Notes to Consolidated Financial Statements.

 

4


Table of Contents

Memry Corporation & Subsidiaries

Consolidated Statements of Cash Flows

For the Nine Months Ended March 31, 2004 and 2003

(Unaudited)

 

     2004

    2003

 

Cash Flows From Operating Activities:

                

Net income

   $ 1,089,000     $ 8,792,000  

Adjustments to reconcile net income to net cash provided by operating activities:

                

Depreciation and amortization

     1,383,000       1,446,000  

Gain on sale of assets

     —         (12,000 )

Deferred income taxes (benefit)

     607,000       (6,877,000 )

Equity based compensation

     176,000       102,000  

Change in operating assets and liabilities:

                

Accounts receivable

     (396,000 )     543,000  

Inventories

     508,000       876,000  

Prepaid expenses and other current assets

     (167,000 )     (59,000 )

Other assets

     33,000       85,000  

Income tax refund receivable

     39,000       —    

Income tax payable

     —         (75,000 )

Accounts payable and accrued expenses

     171,000       (1,018,000 )
    


 


Net cash provided by operating activities

     3,443,000       3,803,000  
    


 


Cash Flows From Investing Activities:

                

Purchases of property, plant and equipment

     (567,000 )     (1,111,000 )
    


 


Cash Flows From Financing Activities:

                

Proceeds from issuance of common stock

     —         48,000  

Proceeds from note payable

     1,574,000       —    

Repayment of notes payable